Carnegie Capital Asset Management, LLC Abbott Laboratories Transaction History

Carnegie Capital Asset Management, LLC

$3.19 Billion
Q1 2024

A detailed history of Carnegie Capital Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 202,561 shares of ABT stock, worth $21.1 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

202,561

Previous 197,731 2.44%

Holding current value

$21.1 Million

Previous $21.8 Million 5.78%

% of portfolio

0.72%

Previous 0.75%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$109.52 - $120.96 $528,981 - $584,236	4,830 Added 2.44%	202,561 $23 Million
Q4 2023 Jan 29, 2024	SELL	$90.19 - $110.4 $451,761 - $552,993	-5,009 Reduced 2.47%	197,731 $21.8 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $520,160 - $624,105	-5,445 Reduced 2.62%	202,740 $19.6 Million
Q2 2023 Aug 04, 2023	SELL	$100.78 - $112.29 $190,675 - $212,452	-1,892 Reduced 0.9%	208,185 $22.7 Million
Q1 2023 Apr 19, 2023	SELL	$96.86 - $114.01 $31,092 - $36,597	-321 Reduced 0.15%	210,077 $21.3 Million

Q4 2022 Jan 23, 2023	BUY	$95.06 - $111.52 $139,928 - $164,157	1,472 Added 0.7%	210,398 $0
Q3 2022 Oct 13, 2022	SELL	$96.76 - $112.03 $737,601 - $854,004	-7,623 Reduced 3.52%	208,926 $20.2 Million
Q2 2022 Aug 02, 2022	BUY	$102.07 - $123.37 $2.54 Million - $3.06 Million	24,838 Added 12.96%	216,549 $23.5 Million
Q2 2022 Jul 13, 2022	SELL	$102.07 - $123.37 $4.53 Million - $5.47 Million	-44,334 Reduced 18.78%	191,711 $22.2 Million
Q1 2022 Apr 11, 2022	BUY	$114.02 - $139.04 $474,551 - $578,684	4,162 Added 1.79%	236,045 $27.9 Million
Q4 2021 Jan 21, 2022	BUY	$115.53 - $141.46 $4.49 Million - $5.5 Million	38,858 Added 20.13%	231,883 $32.6 Million
Q3 2021 Oct 08, 2021	BUY	$116.66 - $129.06 $153,291 - $169,584	1,314 Added 0.69%	193,025 $22.8 Million
Q2 2021 Jul 16, 2021	BUY	$105.79 - $124.53 $788,135 - $927,748	7,450 Added 4.04%	191,711 $22.2 Million
Q1 2021 Apr 12, 2021	BUY	$108.84 - $128.23 $1.2 Million - $1.41 Million	10,998 Added 6.35%	184,261 $22.1 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $5.84 Million - $6.36 Million	55,599 Added 47.25%	173,263 $19 Million
Q3 2020 Oct 13, 2020	BUY	$91.64 - $111.29 $423,651 - $514,493	4,623 Added 4.09%	117,664 $12.8 Million
Q2 2020 Jul 09, 2020	BUY	$76.57 - $98.0 $192,650 - $246,568	2,516 Added 2.28%	113,041 $10.3 Million
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $968,998 - $1.42 Million	15,425 Added 16.22%	110,525 $8.72 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $430,941 - $479,738	5,489 Added 6.13%	95,100 $8.26 Million
Q3 2019 Nov 20, 2019	BUY	$81.84 - $88.74 $57,451 - $62,295	702 Added 0.79%	89,611 $7.5 Million
Q2 2019 Jul 24, 2019	BUY	$72.88 - $85.0 $167,551 - $195,415	2,299 Added 2.65%	88,909 $7.48 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $124,824 - $150,913	1,885 Added 2.22%	86,610 $6.92 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $759,512 - $860,417	-11,585 Reduced 12.03%	84,725 $6.13 Million
Q3 2018 Nov 27, 2018	BUY	$60.81 - $73.36 $1.87 Million - $2.25 Million	30,693 Added 46.78%	96,310 $6.94 Million
Q2 2018 Aug 16, 2018	BUY	$57.57 - $63.54 $201,955 - $222,898	3,508 Added 5.65%	65,617 $4.16 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $180,739 - $204,347	3,212 Added 5.45%	62,109 $3.8 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $725,807 - $777,051	13,521 Added 29.8%	58,897 $3.45 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $31,623 - $35,295	-658 Reduced 1.43%	45,376 $2.55 Million
Q2 2017 Aug 14, 2017	BUY	N/A	46,034	46,034 $2.27 Million

Others Institutions Holding ABT

# of Institutions

3,130

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.

Account

Carnegie Capital Asset Management, LLC Abbott Laboratories Transaction History